# Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine

> **NCT00617058** · PHASE2 · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 1 (actual)

## Conditions studied

- Weight Gain

## Interventions

- **DRUG:** metformin
- **BEHAVIORAL:** healthy lifestyle intervention

## Key facts

- **NCT ID:** NCT00617058
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2010-06
- **Final completion:** 2010-09
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Terminated in lieu of similar,competing large, multi-site study.
- **Last updated:** 2012-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617058, "Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00617058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*